LINAGLIPTIN, A DIPEPTIDYL PEPTIDASE-4 INHIBITOR, IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC LIVER DISEASE: A SINGLE CENTER'S EXPERIENCE
DIABETES RESEARCH AND CLINICAL PRACTICE(2014)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
DIABETES RESEARCH AND CLINICAL PRACTICE(2014)